Journal article icon

Journal article

Survival and desferrioxamine in thalassaemia major.

Abstract:
A small randomised trial and observation of all patients homozygous for beta-thalassaemia in Britain born in or before 1963 indicated that those patients who had received average weekly doses of more than 4 g of desferrioxamine over the previous few years were less likely to die in the near future than were patients of similar ages who had received less, or no, desferrioxamine.
Publication status:
Published

Actions


Authors


More by this author
Institution:
University of Oxford
Department:
Oxford, MSD, Clinical Trial Service Unit
Role:
Author
Journal:
British medical journal (Clinical research ed.)
Volume:
284
Issue:
6322
Pages:
1081-1084
Publication date:
1982-04-05
ISSN:
0267-0623
URN:
uuid:f032844b-3b4c-4848-aaa1-f6ce8426b354
Source identifiers:
42101
Local pid:
pubs:42101

Terms of use


Metrics


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP